Raymond James & Associates Bluebird Bio, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$2.79 - $5.03 $396 - $714	-142 Reduced 1.0%	14,117 $46,000
Q1 2023 Apr 14, 2023	BUY	$3.14 - $8.22 $3,140 - $8,220	1,000 Added 7.54%	14,259 $45,000
Q4 2022 Feb 08, 2023	SELL	$5.77 - $8.49 $1,990 - $2,929	-345 Reduced 2.54%	13,259 $91,000
Q3 2022 Oct 25, 2022	BUY	$3.75 - $7.39 $51,015 - $100,533	13,604 New	13,604 $86,000
Q2 2022 Aug 12, 2022	SELL	$2.94 - $5.23 $30,146 - $53,628	-10,254 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$4.07 - $10.6 $41,733 - $108,692	10,254 New	10,254 $50,000
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $313,700 - $640,826	-18,909 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $174,680 - $240,867	-6,352 Reduced 25.15%	18,909 $818,000
Q3 2020 Nov 04, 2020	BUY	$34.44 - $43.75 $192,347 - $244,343	5,585 Added 28.38%	25,261 $1.36 Million
Q2 2020 Jul 28, 2020	BUY	$27.12 - $45.97 $346,268 - $586,944	12,768 Added 184.83%	19,676 $1.2 Million
Q1 2020 Apr 21, 2020	BUY	$26.16 - $63.5 $6,775 - $16,446	259 Added 3.9%	6,908 $317,000
Q4 2019 Feb 12, 2020	BUY	$46.96 - $61.67 $87,909 - $115,446	1,872 Added 39.19%	6,649 $583,000
Q3 2019 Nov 07, 2019	BUY	$59.47 - $93.1 $21,528 - $33,702	362 Added 8.2%	4,777 $439,000
Q2 2019 Aug 06, 2019	BUY	$75.84 - $105.21 $15,926 - $22,094	210 Added 4.99%	4,415 $562,000
Q1 2019 May 06, 2019	BUY	$64.44 - $104.11 $65,406 - $105,671	1,015 Added 31.82%	4,205 $662,000
Q4 2018 Feb 11, 2019	BUY	$59.1 - $93.26 $45,743 - $72,183	774 Added 32.04%	3,190 $316,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $111,075 - $146,862	-1,250 Reduced 34.1%	2,416 $353,000
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $33,080 - $42,359	-332 Reduced 8.3%	3,666 $575,000
Q1 2018 May 14, 2018	SELL	$105.8 - $150.94 $84,957 - $121,204	-803 Reduced 16.73%	3,998 $683,000
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $84,906 - $136,581	1,045 Added 27.82%	4,801 $855,000
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $102,834 - $162,819	1,781 Added 90.18%	3,756 $516,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,975	1,975 $207,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account